✦ LIBER ✦
210 EML4-ALK is a sensitive client protein of Hsp90, and rearrangements of the ALK locus are associated with clinical response to IPI-504 (retaspimycin hydrochloride), a novel Hsp90 chaperone inhibitor, in patients with non-small cell lung cancer
✍ Scribed by C. Fritz; A. Lim; K. Slocum; C. Tunkey; G. Paez; K. West; R. Ross; E. Normant; L. Sequist; V. Palombella
- Book ID
- 119602891
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 43 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.